
JOURNAL/mgres/04.03/01612956-202701000-00004/figure1/v/2026-11-02T165414Z/r/image-tiff Sevoflurane is a widely used inhaled anesthetic for inducing and maintaining general anesthesia in surgical patients. After inhalation, sevoflurane crosses the alveolar capillary membrane barrier to enter the circulatory system and act on the central nervous system, producing anesthetic effects. Recent research has found that sevoflurane can induce ferroptosis and trigger neurological disorders. However, the exact process behind this is not yet understood. In this study, we used an integrated approach combining bioinformatics analysis with in vivo experiments to investigate the complex relationships between sevoflurane, ferroptosis, and ferritinophagy, along with their underlying mechanisms. By analyzing the sevoflurane anesthesia dataset (GSE139220) in the Gene Expression Omnibus database, we identified the Apelin/early growth response 1 axis as a potential ferroptosis-associated signaling pathway involved in sevoflurane-induced postoperative cognitive dysfunction. The results of in vivo experiment showed that sevoflurane could induce perioperative neurocognitive disorder by reducing the ferroptosis markers glutathione peroxidase 4, xCT, and early growth response 1, as well as increasing the ferritinophagy marker nuclear receptor coactivator 4. Importantly, Apelin-13, a subtype of apelin, reversed these effects. Therefore, we concluded that sevoflurane induces ferritinophagy by regulating the apelin/early growth response 1 axis, thereby exacerbating ferroptosis and inducing cognitive impairment. Apelin-13 may be a promising drug for inhibiting sevoflurane-induced perioperative neurocognitive disorder.
Obstructive sleep apnea is a prevalent sleep-related breathing disorder with recurrent episodes of upper airway collapse during sleep, leading to cyclic blood gas fluctuations. Oxygen, carbon dioxide, and nitric oxide play a crucial role in the pathophysiology. This narrative review aims to explore the role of gases in obstructive sleep apnea pathophysiology, focusing on the molecular pathways and effects of chronic intermittent hypoxia, intermittent hypercapnia, and nitric oxide dysregulation. Chronic intermittent hypoxia stimulates molecular pathways such as hypoxia-inducible factor-1α and inflammatory cascades such as nuclear factor kappa B, leading to oxidative stress, endothelial dysfunction, and sympathetic overactivation. Intermittent hypercapnia impacts on chemoreflex sensitivity, ventilatory instability, and autonomic function, with emerging evidence of both pathogenic and potentially beneficial effects. Nitric oxide, which modulates airway tone, vascular reactivity, and immune control, presents a reduced bioavailability in patients with obstructive sleep apnea. These three gas mediators contribute to the complex pathophysiology of obstructive sleep apnea and underlie the long-term cardiovascular, metabolic, and neurocognitive risks of obstructive sleep apnea. Appropriately prioritizing the relationship between these gases and the pathophysiology of obstructive sleep apnea contributes to a new understanding of the disease and new treatment approaches in the future.
JOURNAL/mgres/04.03/01612956-202701000-00010/figure1/v/2026-11-02T165414Z/r/image-tiff Ozone rectal insufflation possesses anti-inflammatory and antioxidant effects and is used for the treatment and prevention of diseases. This study aimed to investigate the effects of ozone rectal insufflation on chronic obstructive pulmonary disease and explore the potential underlying mechanisms from the perspective of gut microbiology. A mouse chronic obstructive pulmonary disease model was established by intratracheal spraying of lipopolysaccharide and elastase. Mice received ozone rectal insufflation intervention following modeling. We found that ozone rectal insufflation improved pulmonary function, alleviated emphysema and pulmonary fibrosis, and reduced inflammatory cytokine levels in the bronchoalveolar lavage fluid of chronic obstructive pulmonary disease mice. Additionally, ozone rectal insufflation modulated the pathogenic-to-beneficial gut bacteria ratio in chronic obstructive pulmonary disease mice. The treatment also led to an upregulation of short-chain fatty acids. The fecal microbiota transplantation results further confirmed that the gut microbiota of ozone rectal insufflation-treated mice was sufficient to attenuate chronic obstructive pulmonary disease symptoms. In summary, our findings indicate that ozone rectal insufflation enhances lung function and reduces inflammation in chronic obstructive pulmonary disease mice by modulating the gut microbiota and its associated metabolites.